Select Page

ValidCare and the University of Kentucky Research Foundation (UKRF) announced they have partnered to help advance the research of hemp-derived products. The agreement will give hemp-derived product companies access to the broad resources of each organization to conduct clinical and/or observational research related to hemp-derived products and their effects on humans and animals. “Reputable companies are eager to conduct research and better understand the effects of hemp-derived products and their cannabinoid components, like CBD, CBG and CBN, on humans and animals,” says Patrick McCarthy, CEO of ValidCare. “ValidCare is well-positioned to help, and we can’t think of a better research partner than the University of Kentucky Research Foundation.”

From the colleges of Agriculture, Food and Environment to Medicine and Pharmacy, and from data sciences to population health and equine research, ValidCare will have access to an array of highly specialized resources in order to design, execute and accelerate meaningful research on hemp-derived products. “Kentucky is arguably the epicenter of the resurgence of the hemp industry,” says Lisa Cassis, vice president for research at the University of Kentucky. “The university is engaged in hemp research and has been instrumental in FDA-approved studies involving cannabis-based drugs. We have the experience and resources to support ValidCare in conducting data-driven studies to validate hemp-based products’ effects on humans and animals.”